Jubilant Radiopharmacies Logo
  • Why Choose Us
    • History
    • News
    • Industry Insights
    • Our Partnerships
  • Product Portfolio
    • PET Products
    • SPECT Products
    • Therapeutic Products
    • Ancillary Products
  • Our Network
  • Learning Center
  • Careers
  • Order Online
  • Radiopharmacies Division3
    • Radiopharmaceuticals Division
    • Radiopharmacies Division
Jubilant Completes Acquisition of Radiopharmacy Business of Triad Isotopes

Jubilant Completes Acquisition of Radiopharmacy Business of Triad Isotopes

Sep 26, 2017 | News

Jubilant Pharma Limited, a material wholly owned subsidiary of Jubilant Life Sciences Ltd, through one of its wholly owned subsidiaries, has successfully completed the acquisition of Triad Isotopes. Click Here to...
Next Entries »

Recent Posts

  • 5 Trends in Radiopharmaceuticals: What’s Changing and Why It Matters
  • Jubilant Radiopharma and Simplified Imaging Solutions Announce Strategic Partnership to Support the Nuclear Medicine Community
  • Life Molecular Imaging and Jubilant Radiopharma announce Neuraceq® availability in Mobile, AL
  • Jubilant Radiopharma Announces Investment of $50 million (USD) to Expand Positron Emission Tomography (PET) Manufacturing Network
  • Jubilant awarded Radiopharmaceutical Group Purchasing Agreement by Premier

Connect With Us

Corporate Headquarters

      
Jubilant Radiopharmacies Division
790 Township Line Road, Suite 325,
Yardley, PA 19067, USA

 

 215 550 2810

Why Choose Us

Products

Our Network

Patient Notice of Privacy Practices

Learning Center

Careers

Privacy Policy

Code of Conduct

Disclaimer

© 2026 Jubilant Draximage, Inc. dba Jubilant Radiopharma™ A Jubilant Pharma Company

Privacy Policy

Code of Conduct

Disclaimer

© 2026 Jubilant Draximage, Inc. dba Jubilant Radiopharma™ A Jubilant Pharma Company